IMP: Report on the use of capital from public offering

Imexpharm Corporation (IMP) announced the use of proceeds from the public offering as follows:  

1. According to the Resolution of General Meeting of Shareholders dated April 26, 2016, total proceeds from the offering: VND405,195,685,000; Of which:

• Existing shareholders: VND390,725,685,000
• ESOP: VND14,470,000,000

2. At the present, total proceeds have been used until November 12, 2018: VND405,195,685,000; including:

• To invest in High -Tech Pharmaceutical Production Plant in VSIP II Binh Duong Industrial zone: VND355,195,685,000
• To supplement working capital: VND50,000,000,000

HOSE

>   ANV: Notice of stock issuance for the ESOP (13/11/2018)

>   AAA: Report on the result of corporate bonds issuance (13/11/2018)

>   VIB: Notice of record date for Bonus share issue to outstanding shareholders (12/11/2018)

>   MBG: Replacement of the capital auditing report from 01 Jul 2018 to 05 Nov 2018 (12/11/2018)

>   MBG: Report on capital auditing from 01 Jul 2018 to 05 Nov 2018 (09/11/2018)

>   EVS: Notice of record date for seasoned issue (09/11/2018)

>   PAN: Notice of stock issuance for the ESOP (08/11/2018)

>   HPG: Report on the use of capital from public offering (08/11/2018)

>   MIG: Information disclosure about the issue of share to pay dividend (08/11/2018)

>   PWS: Notice of record date for share issuance to outstanding shareholders (07/11/2018)